NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1720170947 MD
Verify on CMS → Attila Lenkey, MD
Pulmonary Disease Physician in Wheeling, West Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
485
Medicare Part D claims · 121 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$80.16
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Attila Lenkey, MD filed 485 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Wheeling, West Virginia, prescribing 56% generic.
- 485
- Part D claims, 2024
- 56%
- generic prescribing
- $80.16
- industry payments (Sunshine Act)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Attila Lenkey, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720170947), first enumerated 09/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 485 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$80.16 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720170947 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1720170947
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- RX-LIGHT 485
- BOOK-THIN 71 in West Virginia
- PHOTO-ENUM Roy Artal · 2006
Attila Lenkey, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
485 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Attila Lenkey, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Attila Lenkey, MD?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
485 68% vs specialty avg
Specialty distribution in West Virginia
How Pulmonary Disease Physician compares to other specialties among West Virginia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720170947 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/28/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Attila Lenkey, MD. Source: openpaymentsdata.cms.gov.
Total received
$80
Largest payer
Avadel CNS Pharmaceuticals, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Attila Lenkey, MD - brand share 44.0%
Pulmonary Disease Physician average
44% brand-name claims vs 56% generic, on 485 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
485
Total Claims
$89K
Total Drug Cost
121
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 636.967
- Total Day Supply
- 18,151
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $85K
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 70.7 years
- Avg HCC Risk Score
- 1.92
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 20, 65-74: 64, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Attila Lenkey, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
79 claims
- Zolpidem Tartrate
Zolpidem Tartrate
50 claims
- Montelukast Sodium
Montelukast Sodium
36 claims
- Trelegy Ellipta
Trelegy Ellipta
34 claims
- Prednisone 27
Prednisone
27 claims
- Stiolto Respimat 26
Stiolto Respimat
26 claims
- Anoro Ellipta 25
Anoro Ellipta
25 claims
- Alprazolam 21
Alprazolam
21 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 79 |
| Zolpidem Tartrate | 50 |
| Montelukast Sodium | 36 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 34 |
| Prednisone | 27 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 26 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 25 |
| Alprazolam | 21 |
| Symbicort Budesonide/Formoterol Fumarate | 20 |
| Temazepam | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Attila Lenkey, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Attila Lenkey, MD's 485 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Lenkey, both outside West Virginia so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in West Virginia
Other clinicians with the same primary specialty enrolled in West Virginia, drawn from the same CMS NPPES roster as Lenkey.
One of 71 Pulmonary Disease Physician providers enrolled in West Virginia, 5 are shown here.
Rime Abbas
Morgantown, WV
Dr. Peter Abbrecht
M.D.
Shepherdstown, WV
Amirahwaty Abdullah
Morgantown, WV
Dr. Roger Abrahams
M.D.
Morgantown, WV
Dr. Jamil Ahmed
MD
Fairmont, WV
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Attila Lenkey, MD's specialty? ▼
Attila Lenkey, MD specializes in Pulmonary Disease Physician and practices in Wheeling, West Virginia. Credentials: MD.
How much does Attila Lenkey, MD prescribe under Medicare Part D? ▼
In 2024, Attila Lenkey, MD wrote 485 Medicare Part D claims totaling $89K in drug costs for 121 beneficiaries.
Where is Attila Lenkey, MD located? ▼
Attila Lenkey, MD is located at 2101 JACOB ST, Wheeling, WV, 26003. Phone: (304) 234-8476.
What is Attila Lenkey, MD's NPI number? ▼
Attila Lenkey, MD's National Provider Identifier (NPI) is 1720170947, issued on 09/28/2006.
Does Attila Lenkey, MD prescribe more brand-name or generic drugs? ▼
Attila Lenkey, MD's prescribing is 44% brand-name and 56% generic drugs by claim count, with $85K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Attila Lenkey, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Attila Lenkey, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Zolpidem Tartrate, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Attila Lenkey, MD accept Medicare? ▼
Attila Lenkey, MD appears in CMS Medicare data with 485 Part D claims and 121 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Attila Lenkey, MD's credentials? ▼
Attila Lenkey, MD's NPI is 1720170947 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.